DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / CHL Medical Partners III, LLC
CHL Medical Partners III, LLC
Institutional venture firm · probableStamford, CTchlmedical.comSEC exempt reporting adviserone firm, 3 filing advisers
This firm files as 3 advisers on chlmedical.com: Collinson Howe & Lennox II, LLC, Collinson Howe & Lennox, LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
venture manager with no reported fund assets yet (scale unknown)
Importance
18
moderate
Active deployment
8
low
Emerging
0
low
Completeness
56
elevated
Freshness
100
high
Research priority
6
low
Identity and regulatory footprint
- Headquarters
- Stamford, CTadviserinfo.sec.gov
- Office address
- 1055 WASHINGTON BOULEVARD, Stamford, CT, 06901adviserinfo.sec.gov
- Business phone
- 203-324-7700adviserinfo.sec.gov
- Website
- HTTPS://WWW.CHLMEDICAL.COM
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- unknown
- Latest Form ADV
- Apr 28, 2014
- Private funds reported
- 2 (2 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $83.7Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Jeffrey J. Collinson Irrevocable Trust-2011 (Owner Class A, B, C), B; Indian Chase, Inc. (Owner Class A, B, C), B
- business email
- info@chlmedical.comchlmedical.compublished by the subject
- business phone
- 203-324-7700adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
- Sectors
- healthcare
- Stages
- early
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 2
Funds and vehicles
0 reported
No vehicle on record yet. A fund arrives from Form ADV Schedule D 7.B.(1) or a Form D filing.
Investment team
14 current, 0 departed
John Joseph Newbury
Board or advisoryTrustee · since Nov 1, 2011
Jeffrey Joseph Collinson
Founder or executiveCeo · since Jul 1, 2006
Ronald William Lennox
OtherVice Prresident · since Jul 1, 2006
Andrew Joseph Collinson
PartnerShareholder · since Jul 1, 2006
Christianne Amon Collinson
PartnerShareholder · since Jul 1, 2006
Gregory M. Weinhoff
PartnerPartner
Jeffrey J. Collinson
PartnerPartner
Myles D. Greenberg
PartnerPartner
Robin Collinson Newman
PartnerShareholder · since Jul 1, 2006
Timothy F. Howe
PartnerPartner
RAE P. Pittman
Platform and operationsSecretary · since Jul 1, 2006
Gregory Mark Weinhoff
Vice presidentVice President · since Jul 1, 2006
Myles David Greenberg
Vice presidentVice President · since Jul 1, 2006
Timothy Furnivall Howe
Vice presidentExecutive Vice President / Owner Class A, B, C · since Jul 1, 2006
Investments on record
2 edges, 2 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Ambra Health | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
| CareWell Urgent Care | portfolio listing | unknown | unknown | unknown | unknown | Sep 16, 2026 | Fact Venture organization websites (about, team, portfolio, thesis, news pages) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
1 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
- Mar 30, 2012CHL Medical Partners III, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012CHL Medical Partners III, L.P. first reported on Form ADV by CHL Medical Partners III, LLC (Venture Capital Fund), GAV $76,683,861Fund first reported on Form ADVFundsFactCHL Medical Partners III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012CHL Medical Partners III Side Fund, L.P. first reported on Form ADV by CHL Medical Partners III, LLC (Venture Capital Fund), GAV $7,065,585Fund first reported on Form ADVFundsFactCHL Medical Partners III Side Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (probable, 70%, cls-1)venture manager with no reported fund assets yet (scale unknown)
Evidence
26 observations from 2 sources